Immunogenicity & Immune Response

• Assays to characterize humoral and cellular immune responses

• Detection of anti-drug antibodies (ADAs)

• Neutralizing antibody (NAb) assays to assess impact on PK, PD, safety, and efficacy

• CD4/CD8 quantitation, B-cell response, cytokine release, and activation assays

• ELISpot and flow cytometry for cellular immunity

Molecular & Virology Testing

• qPCR assays for viral detection and quantification

• Discrimination assays to differentiate wild-type virus from vaccine strains

• Custom biodistribution and viral shedding assays for transmission risk assessment

Assay Development & Validation

• Fit-for-purpose assay development and transfer

• Immunoassays: ELISA, Luminex®, MSD®

• Molecular platforms: qPCR, RT-qPCR, ddPCR, NGS

Vaccine Trial Experience

Proven expertise across multiple vaccine programs, including SARS-CoV-2, Influenza, RSV, HPV, EBV, CMV, Zika, Chikungunya, Dengue, and more.

Eurofins Viracor BioPharma supported assay development, validation, and testing for the Moderna mRNA-1273 COVID-19 vaccine clinical trial, including RT-qPCR and sequencing assays.